WEST LAFAYETTE, Ind. — August 7, 2025 — Leads & Copy — Inotiv, Inc. (NOTV) announced its financial results for the third quarter of fiscal year 2025, which ended June 30, 2025. Revenue for the quarter increased by 23.5% to $130.7 million, while year-to-date revenue rose by 4.0% to $374.9 million.
President and CEO Robert Leasure Jr. noted the company’s progress towards its financial goals, highlighting the revenue and margin improvements over the second quarter. The DSA net awards for the third quarter increased by 25% compared to the previous year, driven by integration, optimization, and startup investments.
Key financial highlights for Q3 FY 2025 include a revenue of $130.7 million, a consolidated net loss of $17.6 million, and an adjusted EBITDA of $11.6 million. The book-to-bill ratio for the DSA services business was 1.07x, with a DSA backlog of $134.3 million as of June 30, 2025.
Year-to-date highlights include a revenue of $374.9 million, a consolidated net loss of $60.1 million, and an adjusted EBITDA of $22.1 million. The book-to-bill ratio for the DSA services business was 1.03x.
Recent developments include the SEC concluding its investigation related to non-human primate importations, with no enforcement action recommended against the company. Inotiv has also recorded a $10.0 million accrual for putative securities class action and shareholder derivative lawsuits, expecting full recovery under existing insurance policies.
Beth A. Taylor, Chief Financial Officer, beth.taylor@inotiv.com, (765) 497-8381
Steve Halper, LifeSci Advisors, shalper@lifesciadvisors.com, (646) 876-6455
Source: Inotiv, Inc.
